The global nasal packing devices market is poised for substantial growth over the next decade, with experts projecting a steady upward trajectory driven by increasing medical needs and innovation in ...

The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

Wearable Furosemide Delivery System Approved for CKD Patients Baqsimi (glucagon nasal powder) Antihypoglycemic Treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

MINT, a stent-free platform, helps treat adult patients undergoing glaucoma angle surgery. The system utilizes a unique ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Researchers have developed a handheld device that could potentially replace stethoscopes as a tool for detecting certain types of heart disease. The researchers, from the University of Cambridge ...

You can reach Rose on Signal at rosebroderick.11. Neuroscientists inched closer last week to developing a commercial device that can instantly translate brain activity into speech for people with ...

CINCINNATI (WKRC)— Researchers at Ohio State University have announced they are the first in the world to test new non-invasive devices aimed ... airflow to the nasal cavity tissue responsible ...

The U.S. Food and Drug Administration classified a recent nasal wash recall for SinuCleanse. The recall, initiated due to microbial contamination, has been officially labeled a Class 1 recall ...

While pharmaceutical companies are safe for the time being from country-specific reciprocal tariffs announced by President Trump Wednesday, medical devices are not. That's according to The ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Researchers at Columbus-based Ohio State University have designed and developed the world’s first noninvasive devices aimed at improving a person’s ability to smell. In a clinical trial, 58 healthy ...